Browse All

Current Filters

CLEAR FILTER x

TITLE

Efficacy, Safety, and Tolerability of Efgartigimod in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: Results from the ADHERE Trial

Fixed-cycle and Continuous Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Study Design of ADAPT NXT

Author:Bril, Vera   Hussain, Yessar   Gwathmey, Kelly   Sahagian, Gregory   Habib, Ali   Claeys, Kristl   Cortes-Vicente, Elena   Brauer, Edward   Gelinas, Deborah   Sumbul, Anne   Jimenez, Rosa   Hristova, Daniela   Mantegazza, Renato   

Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P10.010  

Author Institution:Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, Toronto, Ontario, Canada  University of Toronto, Toronto, Ontario, Canada, Toronto, ON, Canada  Austin Neuromuscular Center, Austin, Texas, Austin, TX  Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, Richmond, VA  The Neurology Center of Southern California, Carlsbad, California, Carlsbad, CA  Department of Neurology, University of California, Irvine, Irvine, California, Orange County, CA  Department of Neurology, University Hospitals Leuven, Leuven, Belgium, Leuven, Belgium  Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, Barcelona, Spain  argenx, Ghent, Belgium, Boston, MA  argenx, Ghent, Belgium, Chapel Hill, NC  argenx, Ghent, Belgium, Tervuren, Belgium  argenx, Ghent, Belgium, Hampton Roads, VA  argenx, Ghent, Belgium, Greater Boston, MA  Department of Neuroimmunology and Neuromuscular Diseases, Fondazione Istituto Neurologico Carlo Besta, Milan, Italy , Milan, Italy